Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - March 2002

  1. From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices JAMA.  2002, %20;287 (7): 833-834.

  2. From the Centers for Disease Control and Prevention. Supply diphtheria and tetanus toxoids and acellular pertussis vaccine  JAMA.  2-6-2002, 287 (5): 579.

  3. From the Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax  JAMA.  2-6-2002, 287 (5): 579.

  4. Small improvements seen in patient, staff vaccinations  Nephrol.News Issues.  2002, 16 (3): 18-25.

  5. Pertussis--United States, 1997-2000  MMWR CDC Surveill Summ.  2-1-2002, 51 (4): 73-76.

  6. Immunization registry use and progress--United States, 2001  MMWR Morb.Mortal.Wkly.Rep.  1-25-2002, 51 (3): 53-56.

  7. Aribas, O. K., Kanat, F., Gormus, N., and Turk, E.  Cold abscess of the chest wall as an unusual complication of BCG vaccination  Eur.J.Cardiothorac.Surg.  2002, 21 (2): 352-354.

  8. Atkinson, W. L., Pickering, L. K., Schwartz, B., Weniger, B. G., Iskander, J. K., and Watson, J. C.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)  MMWR Morb.Mortal.Wkly.Rep.  2-8-2002, 51 (RR-2): 1-35.

  9. Cook, I. F. and Murtagh, J.  Paediatric vaccination practice in a division of general practice  Aust.Fam.Physician.  2001, 30 (12): 1185-1189.

  10. Dalpke, A., Zimmermann, S., and Heeg, K.  CpG-oligonucleotides in vaccination: signaling and mechanisms of action  Immunobiology.  2001, 204 (5): 667-676.

  11. Diodati, C.  Mandatory vaccination of health care workers  CMAJ.  2-5-2002, 166 (3): 301-302.

  12. Downes, K. A., Domen, R. E., McCarron, K. F., and Bringelsen, K. A.  Acute autoimmune hemolytic anemia following DTP vaccination: report of a fatal case and review of the literature  Clin.Pediatr.(Phila).  2001, 40 (6): 355-358.

  13. Eaton, L. 
    New research on autism and measles "proves nothing"  BMJ.  2-9-2002, 324 (7333): 315.

  14. Garcia-Doval, I., Roson, E., Feal, C., De la, Torre C., Rodriguez, T., and Cruces, M. J.  Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid  Acta Derm.Venereol.  2001, 81 (6): 450-451.

  15. Grabenstein, J. D., Guess, H. A., Hartzema, A. G., Koch, G. G., and Konrad, T. R.  Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated  J.Clin.Epidemiol.  2002, 55 (3): 279-284.

  16. Hanna, J. N., Young, D. M., Brookes, D. L., Dostie, B. G., and Murphy, D. M.  The initial coverage and impact of the pneumococcal and influenza vaccination program for at-risk indigenous adults in Far North Queensland  Aust.N.Z.J.Public Health.  2001, 25 (6): 543-546.

  17. Howe, M.  Pneumoccocal vaccination programme begins in Australia  Lancet Infect.Dis.  2001, 1 (2): 69.

  18. Krishna, M. T. and Salvi, S. S.  BCG vaccination and prevention of allergic disease  Pediatrics.  2002, 109 (2): 346-347.

  19. Lathrop, S. L., Ball, R., Haber, P., Mootrey, G. T., Braun, M. M., Shadomy, S. V., Ellenberg, S. S., Chen, R. T., and Hayes, E. B.  Adverse event reports following vaccination for Lyme disease: December 1998--July 2000  Vaccine.  2-22-2002, 20 (11-12): 1603-1608.

  20. Leask, J. and Chapman, S.  'The cold hard facts' immunisation and vaccine preventable diseases in Australia's newsprint media 1993-1998  Soc.Sci.Med.  2002, 54 (3): 445-457.

  21. Lewis, P. R., Reimer, R. F., and Dixon, A. J.  Evaluating the efficacy of vaccine storage in the general practice setting  Aust.N.Z.J.Public Health.  2001, 25 (6): 547-550.

  22. Libman, M. D., Ibrahim, S. A., Omer, M. I., Adlan, I. A., Bellavance, F., Hoskins, E., Bertley, F., and Ward, B. J.  No evidence for short or long term morbidity after increased titer measles vaccination in Sudan  Pediatr.Infect.Dis.J.  2002, 21 (2): 112-119.

  23. Marufu, T. and Siziya, S.  Impact of multiple dose measles vaccination on measles transmission patterns in Gweru, Zimbabwe  J.Trop.Pediatr.  2001, 47 (6): 335-338.

  24. Mazzone, P. J., Mossad, S. B., Mawhorter, S. D., Mehta, A. C., Schilz, R. J., and Maurer, J. R.  The humoral immune response to influenza vaccination in lung transplant patients  Eur.Respir.J.  2001, 18 (6): 971-976.

  25. Morfin, F., Beguin, A., Lina, B., and Thouvenot, D.  Detection of measles vaccine in the throat of a vaccinated child  Vaccine.  2-22-2002, 20 (11-12): 1541-1543.

  26. Mrsny, R. J., Daugherty, A. L., McKee, M. L., and FitzGerald, D. J.  Bacterial toxins as tools for mucosal vaccination  Drug Discov.Today.  2-15-2002, 7 (4): 247-258.

  27. Raaska, K., Raitasuo, V., and Neuvonen, P. J.  Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia  Eur.J.Clin.Pharmacol.  2001, 57 (10): 705-708.

  28. Reinert, P.  The role of pneumococcal and haemophilus type B vaccination in the prevention of acute otitis media  Clin.Microbiol.Infect.  1997, 3 Suppl 3:S59-S61. (): S59-S61.

  29. Riddell, M. A., Leydon, J. A., Ugoni, A., and Kelly, H. A.  A serosurvey evaluation of the school-based measles 'catch-up' immunisation campaign in Victorian school-aged children  Aust.N.Z.J.Public Health.  2001, 25 (6): 529-533.

  30. Rokicka-Milewska, R., Machala, M., Klukowska, A., Laguna, P., and Sikorska-Fic, B.  Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia  Clin.Microbiol.Infect.  1998, 4 (10): 589-593.

  31. Seward, J. F., Watson, B. M., Peterson, C. L., Mascola, L., Pelosi, J. W., Zhang, J. X., Maupin, T. J., Goldman, G. S., Tabony, L. J., Brodovicz, K. G., Jumaan, A. O., and Wharton, M.  Varicella disease after introduction of varicella vaccine in the United States, 1995-2000  JAMA.  2-6-2002, 287 (5): 606-611.

  32. Shah, S., Raman, S., Moreira, C., and MacIntyre, C. R.  School immunisation certificates--a review over time in a disadvantaged community  Aust.N.Z.J.Public Health.  2001, 25 (6): 534-538.

  33. Stephenson, J.  Experts focus on infective agents of bioterrorism  JAMA.  2-6-2002, 287 (5): 575-576.

  34. Strine, T. W., Barker, L. E., Jain, R. B., Washington, M. L., Chu, S. Y., and Mokdad, A. H.  Extraimmunization in children through 2000  JAMA.  2-6-2002, 287 (5): 588-589.

  35. Taylor, B., Miller, E., Lingam, R., Andrews, N., Simmons, A., and Stowe, J.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study  BMJ.  2-16-2002, 324 (7334): 393-396.

  36. Tillmann, B. U., Tillmann, H. C., Nars, P. W., and Weber, P.  Vaccination rate and age of premature infants weighing <1500 g: a pilot study in north-western Switzerland  Acta Paediatr.  2001, 90 (12): 1421-1426.

  37. Tukuitonga, C.  Meningococcal vaccine  N.Z.Med.J.  12-14-2001, 114 (1145): 557.

  38. Uhari, M.  Review: varicella vaccination is effective in children  ACP J.Club.  2002, 136 (1): 25.

  39. Verweij, M. and van Den, Hoven M.  Influenza vaccination rates and informed consent in Dutch nursing homes: survey of nursing home physicians  BMJ.  2-9-2002, 324 (7333): 328.

  40. Weir, E.  Streptococcus pneumoniae infection in children: vaccine implications  CMAJ.  1-22-2002, 166 (2): 220.

  41. Yoshiyama, T.  [Comparison of effectiveness of BCG vaccination and preventive therapy in Japanese settings, with special emphasis on the sensitivity and specificity of tuberculin testing]  Kekkaku.  2002, 77 (1): 11-22.

Back to Top